A. Horwich

19.4k total citations · 1 hit paper
186 papers, 9.8k citations indexed

About

A. Horwich is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, A. Horwich has authored 186 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Surgery, 60 papers in Pulmonary and Respiratory Medicine and 51 papers in Molecular Biology. Recurrent topics in A. Horwich's work include Testicular diseases and treatments (137 papers), Urologic and reproductive health conditions (49 papers) and Sarcoma Diagnosis and Treatment (36 papers). A. Horwich is often cited by papers focused on Testicular diseases and treatments (137 papers), Urologic and reproductive health conditions (49 papers) and Sarcoma Diagnosis and Treatment (36 papers). A. Horwich collaborates with scholars based in United Kingdom, Germany and Norway. A. Horwich's co-authors include Robert Huddart, David P. Dearnaley, Michael Peckham, J. Nicholls, W. F. HENDRY, A. Norman, Sally Stenning, D.P. Dearnaley, Carsten Bokemeyer and Sophie D. Fosså and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

A. Horwich

183 papers receiving 9.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines on Testicular Cancer: 2015 Update

2015 454 citations Carsten Bokemeyer, Gabriella Cohn‐Cedermark et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
A. Horwich	8.1k	2.7k	2.7k	2.5k	2.4k	186	9.8k
Pramod C. Sogani	6.2k 0.8×	2.3k 0.9×	887 0.3×	1.3k 0.5×	618 0.3×	114	7.9k
Robert B. Golbey	2.2k 0.3×	1.9k 0.7×	598 0.2×	782 0.3×	442 0.2×	79	4.8k
Gianni Bisogno	2.6k 0.3×	5.2k 1.9×	1.8k 0.7×	1.3k 0.5×	227 0.1×	336	8.2k
Siamak Daneshmand	8.7k 1.1×	2.5k 0.9×	1.0k 0.4×	1.7k 0.7×	416 0.2×	471	10.9k
Alan Horwich	2.4k 0.3×	5.6k 2.1×	492 0.2×	2.0k 0.8×	348 0.1×	140	10.4k
Suzanne George	2.1k 0.3×	6.8k 2.5×	863 0.3×	1.8k 0.7×	541 0.2×	257	11.7k
Eva Cavallin‐Ståhl	1.6k 0.2×	1.0k 0.4×	398 0.1×	817 0.3×	665 0.3×	119	4.6k
Ugo De Giorgi	2.1k 0.3×	4.7k 1.7×	354 0.1×	2.3k 0.9×	600 0.3×	489	9.0k
Marc B. Garnick	1.6k 0.2×	1.8k 0.6×	363 0.1×	812 0.3×	387 0.2×	133	4.9k
Guy C. Toner	1.4k 0.2×	1.2k 0.4×	361 0.1×	609 0.2×	510 0.2×	124	3.6k

Countries citing papers authored by A. Horwich

Since Specialization

Citations

This map shows the geographic impact of A. Horwich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Horwich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Horwich more than expected).

Fields of papers citing papers by A. Horwich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Horwich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Horwich. The network helps show where A. Horwich may publish in the future.

Co-authorship network of co-authors of A. Horwich

This figure shows the co-authorship network connecting the top 25 collaborators of A. Horwich. A scholar is included among the top collaborators of A. Horwich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Horwich. A. Horwich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bellmunt, Joaquim, Anna Orsola, Jeffrey J. Leow, et al.. (2014). Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 25. iii40–iii48. 248 indexed citations

Oldenburg, Jan, Jorge Aparicio, J. Beyer, et al.. (2014). Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Annals of Oncology. 26(5). 833–838. 45 indexed citations

Oldenburg, Jan, Sophie D. Fosså, Janine Nuver, et al.. (2013). Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 24. vi125–vi132. 179 indexed citations

Schmoll, Hans‐Joachim, Karin Jordan, Robert Huddart, et al.. (2010). Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 21. v147–v154. 81 indexed citations

Schmoll, Hans‐Joachim, Karin Jordan, Robert Huddart, et al.. (2010). Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 21. v140–v146. 53 indexed citations

Schmoll, Hans‐Joachim, Karin Jordan, Robert Huddart, et al.. (2009). Testicular non-seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology. 20. iv89–iv96. 23 indexed citations

Sohaib, S.A., Dow‐Mu Koh, Yolanda Barbáchano, et al.. (2008). Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours. Clinical Radiology. 64(4). 362–367. 60 indexed citations

Gilbert, Duncan C., et al.. (2006). Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy. British Journal of Urology. 98(1). 67–69. 30 indexed citations

Hafeez, S., Ricky A. Sharma, Robert Huddart, D.P. Dearnaley, & A. Horwich. (2006). Challenges in Treating Patients with Down's Syndrome and Testicular Cancer with Chemotherapy and Radiotherapy: The Royal Marsden Experience. Clinical Oncology. 19(2). 135–142. 7 indexed citations

10.

Pico, J L, Giovanni Rosti, A. Kramar, et al.. (2005). A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Annals of Oncology. 16(7). 1152–1159. 169 indexed citations

11.

Fosså, Sophie D., A. Horwich, G Kaiser, et al.. (2005). Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948). British Journal of Cancer. 93(11). 1209–1214. 24 indexed citations

12.

Huddart, Robert, A. Norman, Clare Moynihan, et al.. (2005). Fertility, gonadal and sexual function in survivors of testicular cancer. British Journal of Cancer. 93(2). 200–207. 208 indexed citations

13.

O’Sullivan, Joe M., Robert Huddart, A. Norman, et al.. (2002). Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Annals of Oncology. 14(1). 91–96. 244 indexed citations

14.

Fosså, S.D., et al.. (1996). Optimal field size in adjuvant radiotherapy (XRT) of stage I seminoma - a randomised trial. UCL Discovery (University College London). 8 indexed citations

15.

Eeles, Rosalind A., S. Seal, & A. Horwich. (1994). The incidence of germline p53 mutations in 53 Li-Fraumeni-like families and in individuals with multiple primary tumors. The American Journal of Human Genetics. 55. 1 indexed citations

16.

MacVicar, David & A. Horwich. (1992). Sites of relapse in seminoma treated with single agent carboplatin chemotherapy: Implications for further management. Clinical Oncology. 4(4). 209–213. 3 indexed citations

17.

Hamilton, C.R., Judith M. Bliss, & A. Horwich. (1989). The late effects of cis-platinum on renal function. European Journal of Cancer and Clinical Oncology. 25(2). 185–189. 62 indexed citations

18.

Chilvers, CED, Michael D. Saunders, Judith M. Bliss, J. Nicholls, & A. Horwich. (1989). Influence of delay in diagnosis on prognosis in testicular teratoma. British Journal of Cancer. 59(1). 126–128. 26 indexed citations

19.

Barton, Claire, Gillian Duchesne, M. V. Williams, Cyril Fisher, & A. Horwich. (1988). The impact of hydronephrosis on renal function in patients treated with cisplatin-based chemotherapy for metastatic nonseminomatous germ cell tumors. Cancer. 62(7). 1439–1443. 7 indexed citations

20.

Horwich, A., et al.. (1988). Seminal Analysis after Orchiectomy in Stage I Teratoma. British Journal of Urology. 62(1). 79–81. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact